CRP/DHEA-S ratio · Nutrient Desk

Editorial draft. The text has been read in full and copyedited. Clinical review and source verification are still pending.

What the CRP/DHEA-S ratio is meant to describe

The CRP/DHEA-S ratio divides hs-CRP by DHEA-S to set inflammatory load against anabolic recovery capacity in a single number. CRP is made by the liver in response to immune signals and reflects active inflammation. DHEA-S is a stable, sulfated adrenal hormone that serves as a long-lived reservoir for DHEA and has immunomodulatory effects. Taken together, the two are meant to capture the balance between inflammatory strain and the capacity to regenerate. The source article cites Morgan and colleagues, who are said to have linked higher ratios to all-cause mortality risk in older adults and to have studied them in the context of age-related inflammation (“inflammaging”). Because CRP and DHEA-S are measured in different unit systems and vary by sex and age, there is no single universal cutoff. The ratio is most informative as a personal trend across repeated measurements in the same lab.

Why inflammation and recovery capacity are looked at together

The two markers capture different things. CRP reflects the active inflammatory load at the moment of the blood draw: interleukin-6 and other cytokines instruct the liver to produce it, and once the triggering signal fades it breaks down with a half-life of about 19 hours. The source article describes DHEA-S as a measure of the adrenal glands’ anabolic reserve. It is produced in the zona reticularis and acts as a long-lived pool that peripheral tissues convert into active androgens. In some models this dampens excessive inflammatory signaling while also supporting muscle and connective tissue repair.

The ratio’s added value is supposed to come from the interplay of the two processes. DHEA-S falls by about 10% per decade from the mid-20s onward, a structural, age-related trajectory. The source article also describes suppression under chronically elevated cortisol: cortisol and DHEA synthesis are said to compete for precursors in the zona reticularis, so sustained stress could lower adrenal DHEA-S output regardless of age. The upshot is that a person under chronic psychosocial or physiological stress may have a lower DHEA-S than their age alone would suggest, alongside a higher CRP driven by the same stress-related cytokine activity. The ratio is meant to make visible this combination of inflammation and reduced anabolic reserve, which neither marker captures on its own.

Calculating the CRP/DHEA-S ratio from serum

Formula:

CRP/DHEA-S ratio = hs-CRP (mg/L) ÷ DHEA-S (µg/dL)

Watch the units: hs-CRP is reported in mg/L and DHEA-S in µg/dL, two different unit systems. The numerical value of the ratio is therefore not directly comparable between labs unless the units are confirmed. Some labs and research papers report CRP in mg/dL rather than mg/L, and a ratio calculated from mg/dL values is 10 times smaller than one calculated from mg/L values. Check the units before calculating, and before comparing results across blood draws or labs.

Notes on the blood draw: neither hs-CRP nor DHEA-S requires fasting. DHEA-S shows minimal daily fluctuation, so the timing of the draw is flexible. Ideally, hs-CRP should not be drawn during an acute illness or within two weeks of a vaccination, because the acute-phase response causes a temporary rise that distorts the baseline level of inflammatory activity.

Worked example: a 45-year-old with an hs-CRP of 1.5 mg/L and a DHEA-S of 150 µg/dL has a CRP/DHEA-S ratio of 1.5 ÷ 150 = 0.010. A 65-year-old with a similar lifestyle but an hs-CRP of 2.5 mg/L and an age-related lower DHEA-S of 80 µg/dL has a ratio of 2.5 ÷ 80 = 0.031. That higher ratio reflects both a mild rise in CRP and a marked age-related drop in DHEA-S, a pattern consistent with the course of age-related inflammation observed in cohort research.

How the trend in the CRP/DHEA-S ratio is interpreted

Because the CRP/DHEA-S ratio is not a standardized clinical tool, there is no generally accepted numerical cutoff for the ratio itself. Units differ from lab to lab, and reference intervals differ by sex and age. The most useful approach is to look at the personal trend: same lab and assay, similar draw times and a comparable state of health. Interpretation should be done by a physician who takes your medical history into account. Several measurements show the direction of change better than a single value.

Since there are no cutoffs for the ratio, the individual values can help with interpretation:

hs-CRP below 1 mg/L: Associated with lower cardiovascular risk in large population studies. If the numerator is in this range and DHEA-S is appropriate for age, the ratio is probably in a reassuring range.
hs-CRP 1–3 mg/L: Associated with average cardiovascular risk. With a numerator in this range, the direction of the trend matters, especially if DHEA-S is also falling.
hs-CRP above 3 mg/L: Associated with higher cardiovascular risk when it is persistent and cannot be explained by an acute illness, a recent vaccination or an injury. A numerator in this range, together with low or falling DHEA-S, is meant to point to the combined inflammatory load and reduced anabolic reserve that the ratio is used to examine.
DHEA-S in the lower part of the age- and sex-specific reference range: Even with a modest hs-CRP, a denominator that is low for age raises the ratio. This can stem from an accelerated decline in adrenal function, suppression of the chronic stress axis or medication effects.
DHEA-S unusually high (for example with some symptoms of polycystic ovary syndrome or rare adrenal disorders): The ratio may look reassuringly low, but a very high DHEA-S is not automatically favorable and needs clinical interpretation.

Context remains decisive. A temporary rise in CRP after a half marathon, a vaccination or a short illness is expected and does not mean a lasting change in baseline. Other markers, such as ApoB for lipid-related risk or HbA1c for blood sugar load, round out the picture. This ratio is not a diagnosis.

What raises the CRP/DHEA-S ratio

The IL-6/cytokine axis and CRP

Interleukin-6 and related cytokines are the main signals driving CRP production in the liver. Visceral fat tissue is a source of chronic low-grade IL-6 release, which means excess central obesity keeps up a background inflammatory signal regardless of acute events. In observational and intervention studies, eating patterns that reduce glycemic load and increase omega-3 intake are linked to a lower baseline CRP, probably through reduced glycation stress and a shift in the eicosanoid balance toward fewer pro-inflammatory mediators. Smoking, certain environmental exposures, active autoimmune disease and persistent dental or tissue infections can also raise CRP.

How DHEA-S changes with age

DHEA-S falls by about 10% per decade from the mid-20s. This age-related decline explains why the ratio tends to rise over a lifetime: even if inflammatory load stays the same, a shrinking denominator pushes the ratio up. This trajectory is not as modifiable as CRP, but it matters when interpreting a specific value. A ratio that looks elevated in a 65-year-old may partly reflect normal adrenal aging rather than pathological inflammation.

Chronic stress and the cortisol-DHEA-S axis

Cortisol and DHEA are synthesized along shared precursor pathways in the zona reticularis of the adrenal gland. When cortisol production is chronically elevated, whether from psychosocial stress, disrupted sleep or physiological stressors, DHEA synthesis is competitively suppressed. This means a persistently high cortisol level is associated with a lower DHEA-S regardless of age, which shrinks the ratio’s denominator, while stress-related cytokine signaling can raise the numerator at the same time.

Sleep

Sleep deprivation keeps both sympathetic nervous system activity and cytokine signaling going. Even a few nights of insufficient sleep can raise CRP. Persistent sleep disturbance is associated with altered patterns of adrenal output that can reduce DHEA-S relative to stress demand. Sleep therefore pushes both components of the ratio in the same unfavorable direction.

Medications and other clinical factors

Glucocorticoids suppress ACTH, which reduces adrenal DHEA-S release and shrinks the denominator. They can also suppress CRP acutely, producing a misleadingly low numerator. Statins lower hs-CRP independently of their cholesterol-lowering effect, which can reduce the numerator without any change in the underlying inflammatory biology. Hormonal contraceptives can lower DHEA-S; androgenic medications can raise it. Pregnancy, PCOS and rare adrenal disorders shift both markers in ways that require clinical interpretation before the ratio means anything.

Which other markers help with interpretation

hs-CRP: the numerator. The individual hs-CRP value supplies the cardiovascular risk comparison ranges (<1, 1–3, >3 mg/L) that give the inflammatory component of the ratio a clinical frame.
DHEA-S: the denominator. A standalone DHEA-S result shows where the value sits on the age- and sex-related decline curve, and separates normal aging from stress-related or medication-related suppression.
Cortisol: DHEA-S and cortisol are both adrenal hormones influenced by ACTH. A high cortisol level paired with a low DHEA-S adds the stress-axis dimension that the CRP/DHEA-S ratio cannot distinguish on its own.
ApoB: when CRP is elevated, there is cardiovascular risk that should be considered together with a raised ApoB load. A high CRP/DHEA-S ratio alongside a high ApoB points to a combined inflammatory-atherogenic risk pattern that deserves closer clinical attention.
HbA1c: an elevated HbA1c often goes hand in hand with higher CRP through glycation stress and the buildup of visceral fat. Combining glycemic and inflammatory data places the ratio in its metabolic context.

What intervals are suggested for follow-up measurements

The two components of this ratio move on very different time scales. hs-CRP is fast: it rises within hours of an inflammatory trigger and breaks down with a half-life of about 19 hours. DHEA-S is slow: it reflects adrenal output accumulated over weeks to months and responds to interventions, aging and changes in the stress axis over that same longer period. Because, according to the source article, the meaningful trend is set by the slower change in DHEA-S, the intervals between follow-up measurements should be guided by it.

A retest after three months can confirm the direction of CRP after a lifestyle change, for example after more regular sleep or a change in eating habits. The 6–12-month window is needed to detect a meaningful shift in DHEA-S and therefore in the ratio itself. A retest after less than 6 months is unlikely to pick up a real change in DHEA-S and can lead to a misleading comparison.

For comparable trend measurements, the source article lists the following conditions:

hs-CRP should not be measured within two weeks of an acute illness, a vaccination or a major physical strain. The acute-phase rise distorts the baseline level of inflammatory activity and makes the ratio uninterpretable as a trend point.
Use the same lab and the same assay type (hs-CRP, not standard CRP) for every draw. Switching assay type or lab between draws invalidates the trend, because reference ranges, sensitivity thresholds and unit conventions can differ.
Measure during a stable state of health, outside intense training blocks, active infections or acute periods of heavy stress. The goal is to capture the baseline rather than a temporary change.

When the ratio should be reviewed by a physician

A single elevated ratio is rarely an emergency. The source article lists the following situations in which a physician should review it:

The ratio stays elevated across two or more draws taken at least three months apart during a stable state of health.
hs-CRP is consistently above 3 mg/L without a clear acute explanation such as a recent illness, injury or vaccination.
DHEA-S is low for age and sex, especially combined with elevated cortisol, fatigue or reduced capacity to recover. This pattern may point to dysregulation of the stress axis rather than normal aging alone.
The ratio rises over several blood draws even though lifestyle factors seem stable, which suggests a driver that needs to be investigated.
You are planning to take, or already take, medications that directly affect one or both markers: glucocorticoids, statins, hormonal contraceptives or androgenic agents.
Companion markers such as ApoB or HbA1c are also out of range, pointing to a combined inflammatory-metabolic risk pattern.

Tracking hs-CRP, DHEA-S and their ratio over a longer period helps distinguish a one-off spike from a trend tied to training load, a change in diet, weight change, new medications or a prolonged stretch of stress. The values are easier to interpret when well-being and performance are taken into account too, such as sleep quality, recovery between training sessions and the trend in resting heart rate.

Frequently asked questions

What is the CRP/DHEA-S ratio?

The CRP/DHEA-S ratio is a composite measure that compares high-sensitivity C-reactive protein (hsCRP), a marker of systemic inflammation, with DHEA-S, an adrenal hormone associated with resilience and anabolic balance. A high ratio, meaning elevated inflammation relative to low DHEA-S, has been studied in some research settings as a signal of physiological stress and accelerated biological aging.

How is the CRP/DHEA-S ratio calculated?

The ratio is calculated by dividing hsCRP (in mg/L) by DHEA-S (in µg/dL). Both values come from standard blood tests. There is no generally accepted clinical cutoff, so results are usually interpreted by the direction of change: a ratio that rises over time, or one that is high compared with age-matched norms, should be discussed with a physician.

What does a high CRP/DHEA-S ratio mean?

A high ratio reflects a combination of increased inflammation and reduced androgenic reserve. Research by Morgan and colleagues and others has linked a high CRP/DHEA-S ratio to increased all-cause mortality risk in older adults and to markers of frailty and immune-endocrine imbalance. It is more an indication that catabolic (breakdown) processes predominate than a standalone diagnostic criterion.

What makes CRP rise while DHEA-S falls at the same time?

Chronic psychological or physiological stress is a major reason: cortisol rises (at the expense of DHEA-S production), while low-grade inflammation raises CRP. Contributing factors include poor sleep, visceral obesity, sedentary behavior, chronic disease and aging itself. Both sides of the ratio worsen in parallel as overall metabolic health declines.

What are signs that my CRP/DHEA-S ratio might be unfavorable?

There are no specific symptoms of an elevated CRP/DHEA-S ratio. However, the underlying conditions it reflects, chronic inflammation and falling DHEA-S, are associated with persistent fatigue, reduced physical capacity, slow recovery, low libido and reduced mental performance. A blood test is the only way to quantify the actual ratio.

How can I support a healthier CRP/DHEA-S ratio?

Approaches that reduce CRP (for example better sleep quality, weight management, regular exercise and cutting back on inflammatory eating patterns), along with strategies that support DHEA-S (stress management, enough sleep, strength training), can influence the ratio favorably. Any DHEA supplementation requires medical advice because of its hormonal effects.

How often should I test CRP and DHEA-S?

The source article recommends a baseline measurement of both markers and follow-ups every 6 to 12 months to track the trend. If you are actively changing your lifestyle to counter inflammation or stress, a three-month follow-up can help confirm whether those changes are having a measurable biological effect. Individual readings say less than the direction of change over time.

Is the CRP/DHEA-S ratio used in standard medical care?

The ratio is not yet part of standard clinical guidelines, but it is used in research and in preventive or functional medicine settings to characterize immune-endocrine balance. Both individual markers (hsCRP and DHEA-S) are measured routinely and are well validated. The ratio is meant to add to the interpretation when both are available in the same panel.

Sources and literature

Ridker PM (2016). A Test in Context: High-Sensitivity C-Reactive Protein. Journal of the American College of Cardiology, 67(6), 712-723. https://doi.org/10.1016/j.jacc.2015.11.037 Source
Wu TT, Chen Y, Zhou Y, Adi D, Zheng YY, Liu F, Ma YT, Xie X (2017). Prognostic Value of Dehydroepiandrosterone Sulfate for Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis. Journal of the American Heart Association, 6(5). https://doi.org/10.1161/JAHA.116.004896 Source
Laughlin GA, Barrett-Connor E (2000). Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. The Journal of clinical endocrinology and metabolism, 85(10), 3561-8. https://doi.org/10.1210/jcem.85.10.6861 Source
Vigushin DM, Pepys MB, Hawkins PN (1993). Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. The Journal of clinical investigation, 91(4), 1351-7. https://doi.org/10.1172/JCI116336 Source
Xie S, Galimberti F, Olmastroni E, Luscher TF, Carugo S, Catapano AL, Casula M, META-LIPID Group (2024). Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials. Cardiovascular research, 120(4), 333-344. https://doi.org/10.1093/cvr/cvae034 Source